INTERWEST VENTURE MANAGEMENT CO - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERWEST VENTURE MANAGEMENT CO ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$127,000
-14.2%
8,2930.0%0.05%
+12.8%
Q2 2021$148,0000.0%8,2930.0%0.05%
+20.5%
Q1 2021$148,000
+15.6%
8,2930.0%0.04%
+143.8%
Q4 2020$128,000
+39.1%
8,2930.0%0.02%
-40.7%
Q3 2020$92,000
-11.5%
8,2930.0%0.03%
-68.6%
Q2 2020$104,000
+10.6%
8,2930.0%0.09%
-13.1%
Q1 2020$94,000
-13.8%
8,2930.0%0.10%
+110.6%
Q4 2019$109,000
+45.3%
8,2930.0%0.05%
+62.1%
Q3 2019$75,000
-8.5%
8,2930.0%0.03%
+11.5%
Q2 2019$82,000
-2.4%
8,2930.0%0.03%
-66.2%
Q1 2019$84,000
+61.5%
8,2930.0%0.08%
+5.5%
Q4 2018$52,000
-52.3%
8,2930.0%0.07%
+37.7%
Q3 2018$109,000
+43.4%
8,2930.0%0.05%
+65.6%
Q2 2018$76,000
+230.4%
8,2930.0%0.03%
+220.0%
Q1 2018$23,0000.0%8,2930.0%0.01%
+25.0%
Q4 2017$23,000
-4.2%
8,2930.0%0.01%
+33.3%
Q3 2017$24,000
-7.7%
8,2930.0%0.01%0.0%
Q2 2017$26,000
-21.2%
8,2930.0%0.01%
-14.3%
Q1 2017$33,000
-98.7%
8,293
-97.4%
0.01%
-98.8%
Q4 2016$2,465,000320,0610.59%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders